These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1637011)

  • 1. [The sociopolitical-economic implications of genetic engineering].
    Lamothe Cervera H
    An Esp Pediatr; 1992 Jun; 36 Suppl 48():55-8. PubMed ID: 1637011
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biotechnology in the modern world: benefits and risks].
    Blium IaB
    Tsitol Genet; 2002; 36(1):59-79. PubMed ID: 12012599
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioengineering: the advent of metabiology (part II).
    Bugliarello G
    J Clin Eng; 1981; 6(4):261-7. PubMed ID: 10289333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. India produces homegrown GM cotton.
    Jayaraman KS
    Nat Biotechnol; 2004 Mar; 22(3):255-6. PubMed ID: 14990937
    [No Abstract]   [Full Text] [Related]  

  • 5. The Brethren discuss genetic engineering.
    Hoffman PW
    Brethr Life Thought; 1986; 31(4):201-8. PubMed ID: 16708451
    [No Abstract]   [Full Text] [Related]  

  • 6. Europe sees sharp decline in GMO research.
    Mitchell P
    Nat Biotechnol; 2003 May; 21(5):468-9. PubMed ID: 12721556
    [No Abstract]   [Full Text] [Related]  

  • 7. Health care costs for GEM.
    Jacoby RO
    Comp Med; 2003 Jun; 53(3):242. PubMed ID: 12868564
    [No Abstract]   [Full Text] [Related]  

  • 8. Straight talk with...Joan Scott by Genevive Bjorn.
    Scott J
    Nat Med; 2009 Nov; 15(11):1236-7. PubMed ID: 19893539
    [No Abstract]   [Full Text] [Related]  

  • 9. Private genes and public ethics.
    Moreno JD
    Hastings Cent Rep; 1983 Oct; 13(5):5-6. PubMed ID: 6358124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GM giants pair up to do battle.
    Mitchell P
    Nat Biotechnol; 2007 Jul; 25(7):695-6. PubMed ID: 17621277
    [No Abstract]   [Full Text] [Related]  

  • 11. The biotechnology bubble machine.
    Rasnick D
    Nat Biotechnol; 2003 Apr; 21(4):355-6. PubMed ID: 12665813
    [No Abstract]   [Full Text] [Related]  

  • 12. [Doctors, scientists and patients confront human biological materials research].
    Dubreuil C; Duchier J; Cambon-Thomsen A
    Rev Prat; 2001 Mar; 51(5):469-72. PubMed ID: 11345552
    [No Abstract]   [Full Text] [Related]  

  • 13. Recombinant DNA markets may exceed $3 billion by 1990.
    Am Pharm; 1981 Feb; NS21(2):18. PubMed ID: 6938124
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancement technology, ethics, and public policy.
    Sade RM
    J S C Med Assoc; 1998 Sep; 94(9):411-5. PubMed ID: 9780577
    [No Abstract]   [Full Text] [Related]  

  • 15. Rethinking US leadership in food biotechnology.
    Taylor MR
    Nat Biotechnol; 2003 Aug; 21(8):852-4. PubMed ID: 12894194
    [No Abstract]   [Full Text] [Related]  

  • 16. Genomic sciences and the medicine of tomorrow.
    Drews J
    Nat Biotechnol; 1996 Nov; 14(11):1516-8. PubMed ID: 9634812
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic engineering of millets: current status and future prospects.
    Ceasar SA; Ignacimuthu S
    Biotechnol Lett; 2009 Jun; 31(6):779-88. PubMed ID: 19205896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unlocking the money-making potential of RNAi.
    Howard K
    Nat Biotechnol; 2003 Dec; 21(12):1441-6. PubMed ID: 14647324
    [No Abstract]   [Full Text] [Related]  

  • 19. Cloning endangered animal species?
    Blomquist RF
    Valparaiso Univ Law Rev; 1998; 32(2):383-418. PubMed ID: 12710439
    [No Abstract]   [Full Text] [Related]  

  • 20. A Protestant perspective on the new genetics: are people and institutions of faith prepared to lead?
    Jones JC
    St Thomas Law Rev; 2001; 13(4):927-34. PubMed ID: 12661582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.